Forms
COVID-19 Update:
The "Risks" section in both the IRB application and informed consent form should address the COVID-19 risks your participants may encounter by participating in your research study and how those risks will be mitigated.
- Adverse Event Reporting Form
- Criteria for IRB Approval Reviewer Checklist (for IRB members)
- Informed Consent Form - The "Risks" section should address the COVID-19 risks your participants may encounter by participating in your research study and how those risks will be mitigated.
- Instructions for Accessing CITI Training Modules (including human subjects research)
- IRB Application - The "Risks and Debriefing" section should address the COVID-19 risks your participants may encounter by participating in your research study and how those risks will be mitigated.
- Request for Waiver or Alteration of Informed Consent
- Request for Waiver of Documentation of Informed Consent
- Request for Waiver of Parental Consent—PS 101/102 Students
- Study Closure Form (to be submitted to the IRB within 30 days of study closure)